BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 27762101)

  • 1. Synthesis and evaluation of novel amonafide-polyamine conjugates as anticancer agents.
    Wang Y; Zhang J; Li M; Li M; Xie S; Wang C
    Chem Biol Drug Des; 2017 May; 89(5):670-680. PubMed ID: 27762101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonhematotoxic naphthalene diimide modified by polyamine: synthesis and biological evaluation.
    Wang Y; Zhang X; Zhao J; Xie S; Wang C
    J Med Chem; 2012 Apr; 55(7):3502-12. PubMed ID: 22428910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological evaluation of naphthalimide-polyamine conjugates modified by alkylation as anticancer agents through p53 pathway.
    Dai F; He H; Xu X; Chen S; Wang C; Feng C; Tian Z; Dong H; Xie S
    Bioorg Chem; 2018 Apr; 77():16-24. PubMed ID: 29316508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and Biological Evaluation of Novel Aromatic Imide-Polyamine Conjugates.
    Li M; Wang Y; Zhang J; Xie S; Wang C; Wu Y
    Molecules; 2016 Nov; 21(12):. PubMed ID: 27916902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A naphthalimide-polyamine conjugate preferentially accumulates in hepatic carcinoma metastases as a lysosome-targeted antimetastatic agent.
    Ma J; Li L; Yue K; Zhang Z; Su S; Chen Y; Yu L; Zhang P; Ma R; Li Y; Ma Y; Jia H; Wang C; Wang J; Xie S
    Eur J Med Chem; 2021 Oct; 221():113469. PubMed ID: 33965862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, DNA Binding, and Anticancer Properties of Bis-Naphthalimide Derivatives with Lysine-Modified Polyamine Linkers.
    Huang Y; Wu CX; Song Y; Huang M; Tian DN; Yang XB; Fan YR
    Molecules; 2018 Jan; 23(2):. PubMed ID: 29382135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-Non-amino aromatic substituted naphthalimides as potential antitumor agents: Synthesis via Suzuki reaction, antiproliferative activity, and DNA-binding behavior.
    Xie L; Cui J; Qian X; Xu Y; Liu J; Xu R
    Bioorg Med Chem; 2011 Jan; 19(2):961-7. PubMed ID: 21208805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel metal complexes of naphthalimide-cyclam conjugates as potential multi-target receptor tyrosine kinase (RTK) inhibitors: synthesis and biological evaluation.
    Tan S; Han K; Li Q; Tong L; Yang Y; Chen Z; Xie H; Ding J; Qian X; Xu Y
    Eur J Med Chem; 2014 Oct; 85():207-14. PubMed ID: 25084146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Synthesis and in vitro cytotoxicity of naphthalimide polyamine conjugates as antitumor agents].
    Mei ZH; Tian ZY; Ma HX; Xie SQ; Zhao J; Wang CJ
    Yao Xue Xue Bao; 2009 Jul; 44(7):754-7. PubMed ID: 19806915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel naphthalimide-benzoic acid conjugates as potential apoptosis-inducing agents: design, synthesis, and biological activity.
    Wu A; Mei P; Xu Y; Qian X
    Chem Biol Drug Des; 2011 Dec; 78(6):941-7. PubMed ID: 21958160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of new amonafide analogues via coupling reaction and their cytotoxic evaluation and DNA-binding studies.
    Xie L; Xu Y; Wang F; Liu J; Qian X; Cui J
    Bioorg Med Chem; 2009 Jan; 17(2):804-10. PubMed ID: 19070496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel naphthalimide polyamine derivatives as potential antitumor agents.
    Seliga R; Pilatova M; Sarissky M; Viglasky V; Walko M; Mojzis J
    Mol Biol Rep; 2013 Jun; 40(6):4129-37. PubMed ID: 23640101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxo-heterocyclic fused naphthalimides as antitumor agents: synthesis and biological evaluation.
    Tan S; Yin H; Chen Z; Qian X; Xu Y
    Eur J Med Chem; 2013 Apr; 62():130-8. PubMed ID: 23353750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel naphthalimide derivatives as potential apoptosis-inducing agents: design, synthesis and biological evaluation.
    Wu A; Xu Y; Qian X; Wang J; Liu J
    Eur J Med Chem; 2009 Nov; 44(11):4674-80. PubMed ID: 19643513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis and antitumor evaluation of new 1,8-naphthalimide derivatives targeting nuclear DNA.
    Liang GB; Wei JH; Jiang H; Huang RZ; Qin JT; Wang HL; Wang HS; Zhang Y
    Eur J Med Chem; 2021 Jan; 210():112951. PubMed ID: 33109400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological evaluation of novel alkylated polyamine analogues as potential anticancer agents.
    Li M; Wang Y; Ge C; Chang L; Wang C; Tian Z; Wang S; Dai F; Zhao L; Xie S
    Eur J Med Chem; 2018 Jan; 143():1732-1743. PubMed ID: 29133040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BND-12, a novel nonhaematotoxic naphthalimide derivative, inhibits tumour growth and metastasis of hepatocellular carcinoma.
    Xie SQ; Li Q; Zhang YH; Li Z; Zhao J; Wang CJ
    J Pharm Pharmacol; 2012 Oct; 64(10):1483-90. PubMed ID: 22943179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3-Nitro-naphthalimide and nitrogen mustard conjugate NNM-25 induces hepatocellular carcinoma apoptosis via PARP-1/p53 pathway.
    Xie SQ; Zhang YH; Li Q; Xu FH; Miao JW; Zhao J; Wang CJ
    Apoptosis; 2012 Jul; 17(7):725-34. PubMed ID: 22395446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and anticancer activities of 6-amino amonafide derivatives.
    Norton JT; Witschi MA; Luong L; Kawamura A; Ghosh S; Stack MS; Sim E; Avram MJ; Appella DH; Huang S
    Anticancer Drugs; 2008 Jan; 19(1):23-36. PubMed ID: 18043127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel naphthalimide-amino acid conjugates with flexible leucine moiety as side chain: design, synthesis and potential antitumor activity.
    Wu A; Xu Y; Qian X
    Bioorg Med Chem; 2009 Jan; 17(2):592-9. PubMed ID: 19109022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.